A retrospective observational study to determine glycemic control and risk of hypoglycaemia events on switching to insulin degludec from other long-acting insulins in chronic kidney disease and type 2 diabetes
Latest Information Update: 28 Jul 2020
At a glance
- Drugs Insulin degludec (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 28 Jul 2020 New trial record